AACC conference line-up - First Medical
This article was originally published in Clinica
First Medical introduced its quantitative cardiac marker system which can be used in a point-of-care setting as well as in a STAT laboratory. The company exhibited at the AACC conference held in New Orleans at the end of July. The Alpha Dx, which has already gained US marketing clearance, uses an immunoassay platform to measure the cardiac markers CK, CK-MB, myoglobin and troponin I in less than 20 minutes using whole blood samples.
You may also be interested in...
FDA action awaits Sun’s manufacturing facility in Halol after it failed to adequately address GMP deviations, though India’s top-ranked drug firm appears to have effectively lowered its dependence on the site that has had a patchy compliance run.
In a surprise to the market, Dr Reddy’s and Hikma have prevailed in challenging six method-of-use patents shielding Amarin’s Vascepa in the US, opening the door for a potential at-risk launch that would likely be challenged by the originator.
Duo will study up to four novel preclinical targets identified by Sitryx that may lead to potential new drugs for autoimmune diseases, which Lilly would then commercialize.